A team led by Ilan Matok of Ben-Gurion University of the Negev in Beersheba, Israel, has found that a drug called metoclopramide is safe to use in morning sickness and does not cause any problems for the growing fetus.
The study assessed 81,703 births among women, who were enrolled in a largest health maintenance organization in Israel. Among them 3,458 of the women used to drug to control their morning sickness.
The researchers found no statistically significant differences between women who took metoclopramide and those who did not, adding that these findings "provide reassurance regarding the safety of metoclopramide for the fetus when the drug is given to women to relieve nausea and vomiting during pregnancy."
The details of the study appear in the latest issue of the New England Journal of Medicine.